
Givaudan’s second-quarter organic sales came in ahead of market estimates on Thursday, but its shares fell 5 percent on litigation costs and tariff repayments.
Givaudan’s second-quarter organic sales beat market estimates on Thursday, but its shares fell around 5 percent as litigation costs weighed on profit and tariff repayments clouded the fragrance and flavour maker’s outlook for the rest of 2026.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.
Join thousands of readers who get XOTLIST delivered daily. No spam, ever. Unsubscribe anytime.